ArticleScientific reports2017

Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.

Jinrong Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.